Fierce Biotech September 28, 2022
Joseph Keenan

Emmes has snapped up Clinical Edge for an undisclosed price, extending the Maryland-based CRO’s string of acquisitions to five in just under two years.

Clinical Edge is known for its training and certification of visual function examiners at investigator sites conducting ophthalmic clinical trials. The pairing with Emmes’ Optym ophthalmology certification unit puts the CRO at the head of the pack in such services, the company said in a Sept. 28 release.

With the deal, the company now boasts a base of 36 ophthalmic certifiers, most of whom are doctors of optometry or medicine. Financial terms of the deal weren’t disclosed.

Emmes moved quickly to rebrand the unit as OptymEdge just ahead of this year’s annual meeting of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Mergers & Acquisitions / JV, Trends
Cerevance raises $47m to fund Phase III trial for lead Parkinson’s therapy
Parexel strikes deal with Palantir for clinical trial AI
Risklick debuts new AI software that writes clinical trial protocols
“Intentional effort” needed from sponsors to achieve diversity in oncology clinical trials
It’s Time to Give Patients a Seat at the Table

Share This Article